Literature DB >> 30083555

A Rare Case of Raoultella planticola Urinary Tract Infection in a Patient With Immunoglobulin A Nephropathy.

Hassan Mehmood1,2, Najwa Pervin3, Muhammad Israr Ul Haq4, Khushbakht Ramsha Kamal5, Asghar Marwat1,2, Muzammil Khan1,2.   

Abstract

Raoultella planticola is a gram-negative, aerobic, nonmotile mostly found in environments with high prevalence in soil and water. This organism is a very rare human pathogen as only 29 cases of Raoultella planticola-related infections have been reported until 2017, with only 7 cases in the United States. Only 3 cases of urinary tract infection secondary to R planticola have been reported, 1 in a pediatric patient and 2 in adults. In this article, we present a case of R planticola urinary tract infection in a 65-year-old male with immunoglobulin A nephropathy. On investigation, the patient was found to be septic and empirical antibiotic was started for gram-negative coverage. The patient showed remarkable improvement and discharged on oral antibiotic for 7 days. R planticola rarely cause infection in humans, with overall good prognosis.

Entities:  

Keywords:  IgA nephropathy; Raoultella planticola; antibiotic; urinary tract infection

Year:  2018        PMID: 30083555      PMCID: PMC6062772          DOI: 10.1177/2324709618780422

Source DB:  PubMed          Journal:  J Investig Med High Impact Case Rep        ISSN: 2324-7096


Introduction

Raoultella planticola is a gram-negative, aerobic, nonmotile mostly found in environments with high prevalence in soil and water. It was first described in the 1980s as Klebsiella planticola and Klebsiella trevisanii.[1] It was reclassified into a new genus in 2001 as Raoultella planticola.[2] This organism is a very rare human pathogen as only 29 cases of R planticola–related infections have been reported until 2017, with only 7 cases in the United States. Only 3 cases of urinary tract infection secondary to R planticola have been reported, 1 in a pediatric patient and 2 in adults.[3,4] In this article, we present a case of R planticola urinary tract infection in 65-year-old male with immunoglobulin A nephropathy.

Case Presentation

A 65-year-old male with past medical history of hypertension, diabetes mellitus type 2, hyperlipidemia, and end-stage renal diseases secondary to biopsy-proven immunoglobulin A nephropathy came to our hospital with dysuria, dark urine, and fever going on for the last 3 days. His vitals showed a temperature of 39.3°C, blood pressure of 164/89 mm Hg, pulse of 99 beats per minute, and respiratory rate of 20 breaths per minute. The examination was unremarkable except for mild lower abdominal tenderness. Initial laboratory workup was remarkable for white blood cells (WBCs) of 10 900/µL (3100-8500/µL), neutrophil percentage of 87% (25% to 62%), absolute neutrophils of 9500/µL (1700-6300/µL), platelets of 174 000/µL (140 00-440 000/µL), sodium of 135 mmol/L (136-145 mmol/L), lactic acid of 1.1 mmol/L (0.5-2.2 mmol/L), blood urea nitrogen of 47 mg/dL (9-21 mg/dL), and creatinine of 4.5 mg/dL (0.6-1.1 mg/dL). Urine analysis showed 1+ bacteria, large leukocytes, WBC >50/high-power field (HPF), and squamous epithelial cells 0 to 5/HPF. Keeping in mind urosepsis, blood cultures were drawn from 2 peripheral sites along with urine culture, and he was started on intravenous ceftriaxone and intravenous fluid as per sepsis protocol. Nephrology was consulted and the patient got dialysis the next day secondary to end-stage renal diseases. The patient started showing improvement. On day 2, the patient was afebrile, and WBC started trending down along with resolution of dysuria. Blood cultures did not grow anything, but 3 days later urine culture grew R planticola sensitive to all main-line antibiotics, including ceftriaxone, ciprofloxacin, nitrofurantoin, cefazolin, gentamicin, and trimethoprim-sulfamethoxazole. The patient was subsequently discharged on the fourth day on ciprofloxacin renal dose 250 mg orally every 12 hours for 4 more days to complete 7 days of treatment. The patient was seen in clinic after 2 weeks with complete resolution of symptoms.

Discussion

Raoultella planticola is an encapsulated, nonmotile, aerobic, gram-negative rod predominantly found in water and soil. Although R planticola is mainly an aquatic and soil bacterium, it has been clinically isolated from human sputum, stool, wound, and urine. To date, 29 cases of human infection with R planticola has been reported with only 3 urinary tract infections.[3,4] R planticola is difficult to isolate and to identify, as it can easily be confused with other genera, especially klebsiella.[5] R planticola rarely cause infection in healthy individuals. Malignancy, transplant recipients, dialysis-dependent patients, diabetes mellitus, and immunocompromised state also put them at high risk.[6-9] Raoultella planticola has been associated with cases of pneumonia, urinary tract infection, cholangitis, conjunctivitis, peritonitis, necrotizing fasciitis, bacteremia, cellulitis, and soft tissue infection. On literature review of 29 reported cases, 3 patients died, 22 patients had full recovery, and 4 patients had an unknown outcome. Mortality is high in immunocompromised patients.[3] The First reported human infection due to Klebsiella trevisanii (later reclassified as R planticola) was in 1986, which included bacteremia in a 69-year-old patient.[10] In 2014, a case of R Planticola bacteremia in a 56-year-old female was reported following consumption of seafood salad containing squid and octopus.[5] As there is limited data regarding this pathogen, especially in humans, the mechanism of its pathogenesis remains unclear. Immunocompromised state, proton pump inhibitor use, and chemotherapy increase the chances of infection. R planticola has the ability to change histidine to histamine leading to scombroid poisoning when poorly cooked sea food eaten in a large quality.[5] Variety of human organ systems had been affected, with no predilection for a particular organ system. Culture along with VITEK-2 (bioMerieux) automated bacterial identification system not only help in identification of R planticola but is also highly sensitive in differentiating between Raoultella and Klebsiella. Treatment of R planticola urinary tract is mainly empiric antibiotic for gram-negative coverage and should be narrowed accordingly when further microbiologic information is available. Usually R planticola is sensitive to all main-line gram-negative covering antibiotics; however, multidrug-resistant strains of R planticola have been isolated from both patients and the environment.[11-13] Our patient did not show resistance to any antibiotic.

Conclusion

In conclusion, infection due to R planticola has been on the rise recently. The organism has been involved in infecting multiple organ systems. Individuals who are immunocompromised, have multiple comorbid diseases, and dialysis patients are at risk. Avoidance of contaminated water is the key to prevention. R planticola infection has good prognosis overall. It is prudent to be aware of this human pathogen and early initiation of antibiotics is the main treatment. As with any other human pathogen, we recommend closely monitoring its pattern of resistance.
  13 in total

1.  A case of Raoultella planticola causing a urinary tract infection in a pediatric patient.

Authors:  Cailly Howell; Joseph Fakhoury
Journal:  Transl Pediatr       Date:  2017-04

2.  Phylogenetic analyses of Klebsiella species delineate Klebsiella and Raoultella gen. nov., with description of Raoultella ornithinolytica comb. nov., Raoultella terrigena comb. nov. and Raoultella planticola comb. nov.

Authors:  M Drancourt; C Bollet; A Carta; P Rousselier
Journal:  Int J Syst Evol Microbiol       Date:  2001-05       Impact factor: 2.747

3.  Cholangitis with septic shock caused by Raoultella planticola.

Authors:  Kazuhisa Yokota; Harumi Gomi; Yoshimasa Miura; Kentaro Sugano; Yuji Morisawa
Journal:  J Med Microbiol       Date:  2011-11-17       Impact factor: 2.472

4.  First descriptions of blaKPC in Raoultella spp. (R. planticola and R. ornithinolytica): report from the SENTRY Antimicrobial Surveillance Program.

Authors:  Mariana Castanheira; Lalitagauri M Deshpande; Joseph R DiPersio; Julia Kang; Melvin P Weinstein; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2009-10-07       Impact factor: 5.948

5.  Raoultella planticola bacteremia following consumption of seafood.

Authors:  Philip W Lam; Irving E Salit
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-07       Impact factor: 2.471

6.  First Report of bla(IMP-8) in Raoultella planticola.

Authors:  Sung-Pin Tseng; Jann-Tay Wang; Chih-Yuan Liang; Pei-Shan Lee; Yee-Chun Chen; Po-Liang Lu
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

7.  Multidrug and heavy metal-resistant Raoultella planticola isolated from surface water.

Authors:  Serkan Koc; Burak Kabatas; Bulent Icgen
Journal:  Bull Environ Contam Toxicol       Date:  2013-06-11       Impact factor: 2.151

8.  Nosocomial infection and colonization by Klebsiella trevisanii.

Authors:  J Freney; F Gavini; H Alexandre; S Madier; D Izard; H Leclerc; J Fleurette
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

9.  Necrotizing fasciitis involving the chest and abdominal wall caused by Raoultella planticola.

Authors:  Si-Hyun Kim; Kyoung Ho Roh; Young Kyung Yoon; Dong Oh Kang; Dong Woo Lee; Min Ja Kim; Jang Wook Sohn
Journal:  BMC Infect Dis       Date:  2012-03-17       Impact factor: 3.090

10.  A rare case of Raoultella planticola urinary tract infection in an immunocompromised patient with multiple myeloma.

Authors:  William Paul Skelton; Zachary Taylor; Jack Hsu
Journal:  IDCases       Date:  2017-02-10
View more
  2 in total

1.  A 5-Year Retrospective Analysis of Raoultella planticola Bacteriuria.

Authors:  Sai Vikram Alampoondi Venkataramanan; Lovin George; Kamal Kant Sahu; George M Abraham
Journal:  Infect Drug Resist       Date:  2021-05-31       Impact factor: 4.003

2.  CTX-M-9 group ESBL-producing Raoultella planticola nosocomial infection: first report from sub-Saharan Africa.

Authors:  Tafese Beyene Tufa; Andre Fuchs; Torsten Feldt; Desalegn Tadesse Galata; Colin R Mackenzie; Klaus Pfeffer; Dieter Häussinger
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-08-17       Impact factor: 3.944

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.